MACC1 Expression in Colorectal Cancer Is Upregulated by Loss of Epigenetic Repression Under Oxidative Stress Condition
Cell Biochemistry and Function · 2025
DOI: 10.1002/cbf.70107 ↗At a glance
Journal article in Cell Biochemistry and Function, 2025. Written by Suchittra Phoyen and 4 co-authors. Institution: Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Major MEDLINE topics: Oxidative Stress, Colorectal Neoplasms, Transcription Factors, Epigenesis, Genetic. Cited 4 times so far (Crossref); 40 references. Funded by: The study was funded by the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University (CU_GR_63_116_30_23 to C.B.), Thailand Science Research and Innovati…, National Research Council of Thailand.
Abstract (original language)
Reactive oxygen species (ROS) cause oxidative stress and contribute to cancer genesis and progression. Metastasis‐associated in colon cancer 1 (MACC1) is a key metastasis‐mediating transcription factor in colorectal cancer (CRC). Whether ROS epigenetically regulated MACC1 expression and increased tumor progression in CRC have not been elucidated so far. We applied oxidative stress in two CRC cell lines with differential MACC1 expression (HCT116 and SW480) and analyzed the distribution of the histone marks H3K4me3 (active) and H4K20me3 (repressive), as well as the expression of MACC1. Alteration in cell motility by ROS was assayed with Boyden chambers. Abundance of H4K20me3 on the MACC1 promoter was determined by ChIP‐seq. Induced oxidative stress in SW480 and HCT116 cells increased MACC1 mRNA and protein expression and enhanced cell migration. In the low MACC1 expression SW480 cells, oxidative stress resulted in a higher abundance of the active histone mark H3K4me3, and a lower abundance of repressive mark H4K20me3, both overall and specifically on the MACC1 promoter, compared with the medium MACC1 expression HCT116 cells. Analysis of histological abundances of H3K4me3 and H4K20me3 marks in a small panel of human CRC tumors showed an inverse correlation of H4K20me3 with MACC1. Experimentally, inhibition of H4K20me3 formation caused increased MACC1 mRNA expression in HCT116 cells. Conclusions, we reported a potential ROS‐mediated epigenetic regulation of MACC1 expression in CRC through altered histone methylation, as our data suggested an initial epigenetic silencing of MACC1, which was later partially reactivated under oxidative stress.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Experimental and Clinical Research Center, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and Charité-Universitätsmedizin, Berlin, Germany.
- German Cancer Consortium (DKTK Partnersite Berlin), Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, Heidelberg, Germany.
- Petra Christian University (Honorable Guest Professor), Surabaya, Jawa Timur, Indonesia.
ORCID profiles: Chanchai Boonla
Funding
- The study was funded by the Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University (CU_GR_63_116_30_23 to C.B.), Thailand Science Research and Innovati…
- National Research Council of Thailand
Cite
APA
Phoyen, S., Dahlmann, M., Herrmann, P., Boonla, C., & Stein, U. (2025). MACC1 Expression in Colorectal Cancer Is Upregulated by Loss of Epigenetic Repression Under Oxidative Stress Condition. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70107
Vancouver
Phoyen S, Dahlmann M, Herrmann P, Boonla C, Stein U. MACC1 Expression in Colorectal Cancer Is Upregulated by Loss of Epigenetic Repression Under Oxidative Stress Condition. Cell Biochemistry and Function. 2025. doi:10.1002/cbf.70107
BibTeX
@article{Phoyen2025,
author = {Phoyen, Suchittra and Dahlmann, Mathias and Herrmann, Pia and Boonla, Chanchai and Stein, Ulrike},
title = {MACC1 Expression in Colorectal Cancer Is Upregulated by Loss of Epigenetic Repression Under Oxidative Stress Condition},
journal = {Cell Biochemistry and Function},
year = {2025},
doi = {10.1002/cbf.70107}
}
EUVIMED